Table 4 Uni- and multivariate Cox regression analysis of overall survival prognosis in TCGA dataset.
From: RBM47 is a novel immunotherapeutic target and prognostic biomarker in gliomas
Variable | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
HR (95% Cl) | P-value | HR (95% Cl) | P-value | |
WHO grade | ||||
 G2 | Reference |  |  |  |
 G3 | 3.297 (1.996–5.447) |  < 0.001 | 2.106 (1.249–3.552) | 0.005 |
 G4 | 20.691 (12.401–34.521) |  < 0.001 | 3.391 (1.770–6.496) |  < 0.001 |
Gender | 1.007 (0.744–1.364) | 0.962 |  |  |
Age | 1.077 (1.064–1.090) |  < 0.001 | 1.061 (1.044–1.078) |  < 0.001 |
IDH | 0.090 (0.063–0.128) |  < 0.001 | 0.435 (0.245–0.775) | 0.005 |
1p19q | 0.220 (0.130–0.375) |  < 0.001 | 0.742 (0.382–1.442) | 0.379 |
MGMT | 0.306 (0.219–0.426) |  < 0.001 | 0.821 (0.558–1.207) | 0.316 |
RBM47 expression | 1.721 (1.516–1.953) |  < 0.001 | 1.334 (1.136–1.566) |  < 0.001 |
